Screener
Mirum Pharmaceuticals, Inc. MIRM Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Amortized Cost | Unrealized Gain | Unrealized Loss | Estimated Fair Value |
|---|---|---|---|---|
| Agency bonds | 16,500 | — | (69) | 16,431 |
| Commercial paper | 17,970 | — | — | 17,970 |
| Total cash equivalents and investments | $493,743 | $6 | $(472) | $493,277 |
| Classified as: | ||||
| Cash equivalents | $262,684 | |||
| Short-term investments | 107,563 | |||
| Long-term investments | 123,030 | |||
| Total cash equivalents and investments | $493,277 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s short-term investments?
- Mirum Pharmaceuticals, Inc. (MIRM) reported short-term investments of $107.56M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s short-term investments increased by 40.7% year-over-year, from $76.43M to $107.56M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s short-term investments has grown at a -0.7% compound annual growth rate (CAGR), from $89.73M to $86.64M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Mirum Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude